Skip to main content
. 2020 Oct 22;254:117232. doi: 10.1016/j.carbpol.2020.117232

Fig. 2.

Fig. 2

Schematic illustration of anticoagulant activity of heparin in COVID-19. Heparin binds with AT-III and induces a conformational change of AT-III for activation. The activated AT-III further inactivates coagulation factors (XIIa, XIa, IXa, Xa and IIa) and inhibits the formation of thrombosis.